Article
Non-invasive foetal RhD genotyping: A strategy for rationalizing anti-D immunoglobulin prophylaxis in RhD-negative pregnant women at the Hospital Italiano de Buenos Aires.
Vox sanguinis - 1 Feb 2026
Santoro Diego Mario, Gonzalez Hermida Paula, Gamboa Carla Virginia, Garcia Rivello Hernan Jorge, Meller Cesar, Otaño Lucas, Aiello Horacio Antonio, Camino Pablo Javier, Burgos Pratx Leandro Daniel
Abstract excerpt
BACKGROUND AND OBJECTIVES: The administration of anti-D immunoglobulin achieved a significant reduction in the mortality of haemolytic disease of the foetus and the newborn due to RhD sensitization. Between 30% and 40% of this group of pregnant women, carriers of an RhD-negative foetus, would unnecessarily receive a high-cost drug, exposing them to the risks of a blood derivative. The aim of the study was to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.